The five-step synthesis of the new 4H-anthra[1,2-b]pyran derivative 1 is reported. The key steps in this approach included a Marschalk alkylation of 1,4-dihydroxyanthraquinone followed by a Baker-Venkataraman reaction and then an acid-catalyzed cyclization of ring A to form the 4H-anthra[1,2-b]pyran system. Two compounds, the 4H-anthra[1,2-b]pyran 1 and the anthraquinone derivative 6 were evaluated for antimicrobial activity and showed moderate antialgal, antifungal, and antibacterial activities.
The 4H-anthra [1,2-b] pyran system provides the cyclic skeleton of the aglycones of the natural antitumor antibiotics of the pluramycin group and their biologically active C-glycosides [1] . The 4H-anthra [1,2-b] pyran antibiotics of the heydamycin or pluramycin type are known for their antibacterial and antitumor activity [1b] . Our interest in the synthesis of 4H-anthra[1,2-b]pyran derivatives was stimulated as a result of their remarkable antitumor activity [2, 3] and neuronal cell protecting property [4] . Some 4H-anthra [1,2-b] pyran antibiotics were found to be potent inhibitors of IL-4 signal transduction and showed inhibition of the A431 cell line in µmolar concentrations [2] . More recently, the topopyrones, notably topopyrone C (Scheme 1), have aroused interest as selective topoisomerase I inhibitors [3] .
We now report our work on the synthesis of 4H-anthra[1,2-b]pyrone derivative 1. We wanted to probe if a) the aglycone was biologically active without the specific substitution pattern found in topopyrone C; b) to make this class of compounds readily available in substantial amounts for antimicrobial testing. The key steps in the approach included a Marschalk alkylation [5] reaction of hydroxylated anthraquinones followed by a Baker-Venkataraman rearrangement and then an acidcatalyzed cyclization to form 1 [2].
In the original version of the Marschalk reaction [6] , phenolic dihydroanthraquinones are alkylated in the position ortho to the phenolic hydroxy group by heating at reflux with aldehydes under basic conditions. At low temperatures, however, the originally introduced hydroxyalkyl group may be preserved if the intermediate hydroquinones are rapidly re-oxidized to the quinones using hydrogen peroxide in an alkaline reaction medium [2, 5] .
This reaction was used to introduce a hydroxyethyl side chain into the initially selected 1,4-dihydroxyanthraquinone 2 to form the hydroxyethyl compound 3 (Scheme 1). The reaction temperatures had to be adjusted for the different reactivities of the corresponding hydroquinones and the optimal temperature was 5 °C for 1,4-dihydroxyanthraquinone 2. The oxidation of the hydroxyethyl group in 3 to the methyl ketone 5 was achieved by using 1-hydroxy-1-oxo-1H-1λ 5 -benzo[d] [1, 2] iodoxol-3-one (IBX) with 75% yield. The acylation product 5 was obtained in 89% yield by acylation with propionyl chloride and pyridine. Several bases were used to initiate the subsequent intramolecular acylation (Baker-Venkataraman reaction). In our hands, lithium hydride in boiling THF [2, 7] gave the best results and the β-diketone 6 was isolated in 89% yield.
Finally, acid-catalyzed cyclization of the diketone 6 was achieved in the presence of conc. HCl and acetic acid in 77% yield. Mechanistically, the reaction can be easily understood as a reversible hemiketal formation involving the phenolic group and the 3'-oxo group, followed by irreversible water elimination to form the pyranone ring [2b].
842 Natural Product Communications Vol. 6 (6) Antimicrobial activity: Two compounds, the 4Hanthra[1,2-b]pyran derivative 1 and the anthraquinone derivative 6 were selected to test for antimicrobial activity. Interestingly, both compounds 1 and 6 inhibited all tested organisms and showed also moderate antialgal, antifungal, and antibacterial activities (Table 1) . 
Experimental

General experimental procedures:
For general methods and instrumentation see ref. [8] .
Hydroxyethylation of 1,4-Dihydroxyanthraquinone (3):
A solution of the 1,4-dihydroxyanthraquinone 2 (10 g, 46 mmol) in methanol (40 mL) was first treated at 20C with an aqueous NaOH solution (10 mL, 1M) and then under nitrogen with a solution of sodium dithionite (20 mL, 0.5M). The color changed from purple-red to brownishyellow after the dithionite reduction. Acetaldehyde (35.4 mmol, 2 mL) was then added and stirring at 5C was continued until the starting material was almost (ca. 90 %) consumed (TLC control, ca. 2 h). The solution was diluted with water and hydrogen peroxide (3%, ca. 10 mmol) was added for re-oxidation of the dihydroanthraquinones to the anthraquinones. The solution was acidified with 2 mol/L HCl (10 mL), the precipitate collected by filtration and the aqueous phase extracted with dichloromethane (10 mL). The carefully dried precipitate and the residue from the extraction were combined and purified by stirring with dry dichloromethane (10 mL) and filtration to remove unreacted starting material and some 2-ethyl-1,4dihydroxyanthraquinone to afford 6.5 g of 1,4-dihydroxy-2-(1-hydroxyethyl)anthracene-9,10-dione (3) 
2-Acetyl-1,4-dihydroxyanthraquinone (4) [2b]:
Propionylation of 1,4-Dihydroxy-2-(1-hydroxyethyl) anthraquinone (5):
To a solution of 4 (288 mg, 1.02 mmol) in dry CH 2 Cl 2 (40 mL), pyridine (2.0 mL), propionyl chloride (0.43 mL, 5 mmol) and DMAP (3 mol %) were added successively. The solution was stirred at 20C for approximately 3 h (TLC control). The solution was then diluted with dichloromethane (100 mL) and poured into ice-cold HCl (2 mol/L). The phases were separated and the organic phase was first washed with dilute aqueous NaHCO 3 solution (2 × 10 mL) and then with brine (20 mL). The organic phase was dried with MgSO 4 , the solvent removed under reduced pressure and the resultant crude product purified by column chromatography and finally crystallization from CH 2 Cl 2 /petroleum ether afforded red crystals of 5 (338 mg, 0.92 mmol, 90%). 1 H NMR (500 MHz, CDCl 3 ): δ 1.40 (m, 6H, CH 3 ), 2.49 (s, 3H, CH 3 ), 2.80 (m, 4H, CH 2 ), 7.74 (s, 1H, H-3'), 7.75-7.81 (m, 2H, H-5', H-8'), 8.13-8.21 (m, 2H, H-6', H-7') . HREIMS: m/z 394.1045 (calcd. 394.1053 for C 22 H 18 O 7 ).
Baker-Venkataraman Rearrangement of 5:
LiH (22 mg, 2.83 mmol) was added at 0C to a solution of 5 (338 mg, Preparation and antimicrobial activity of an anthrapyran derivative Natural Product Communications Vol. 6 (6) 2011 843 0.85 mmol) in dry THF (50 mL) and the suspension was heated to reflux under argon for ca. 12 h (TLC control). After cooling to 20C, the solution was neutralized at 0C by addition of HCl (2 N, 4 mL). The solvent was removed under reduced pressure, the residue re-dissolved in CH 2 Cl 2 (30 mL), the organic phase washed with HCl (2 N, 2 × 10 mL) and water (2 × 10 mL), dried with Na 2 SO 4 and filtered. The solvent was removed under reduced pressure and the crude product was purified by crystallization from CH 2 Cl 2 /diethyl ether to yield 6 as yellow crystals (257 mg, 0.88 mmol, 89%). (6) MP: 161C. 1H NMR (500 MHz, CDCl 3 ) (enol): δ 1.25 (t, 3H, CH 3 ), 2.50-2.60 (q, 2H, CH 2 ), 3.80(s, 2H, CH 2 ), 6.14 (s, 1 H, H-2), 8.08 (s, 1H, H-3), 8.24-8.29 (m, 2H, H-5, H-8), 8.34-8.39 (m, 2H, H-6, H-7) , 14.10 (s, 1H, OH), 14.20 (s, 1H, OH 
1,4-Dihydroxy-2-(3-oxopentanoyl)anthraquinone
Acid-catalyzed ring closure of β-diketone 6 to
Anthrapyranone 1: Concd. HCl (0.2 mL) was added to a solution of 6 (190 mg, 0.56 mmol) in acetic acid (10 mL). The solution was stirred at 100-110C for ca. 6 h (TLC control). After cooling to 20C, EtOAc (100 mL) was added and the solution was washed successively with water (3× 15 mL) and a dilute aqueous NaHCO 3 solution (3× 15 mL). The organic phase was dried with Na 2 SO 4 , filtered, and the solvent was removed under reduced pressure. The crude product was purified by crystallization to afford pale yellow crystals of 1 after crystallization from CH 2 Cl 2 /diethyl ether (137 mg, 77%,). -6-hydroxy-4H-naphtho[2,3-h]chromene-4,7 ,12trione (1) MP: 243°C. IR (KBr, cm -1 ): ν = 1763, 1670 , 1647 , 1589 , 1562 , 1431 , 1392 , 1350 , 1292 , 1246 , 1223 , 1200 , 1173 , 1149 , 1022 
2-Ethyl
